3 September 2021 Current Affairs
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
Hyderabad-based Biological E Limited got approval from the Drug Controller General of India (DCGI) to conduct Phase 2 & 3 clinical trials for its COVID-19 vaccine Corbevax on children aged between 5 and 18 years of age with certain conditions.
Odisha-born neurosurgeon Dr Basant Kumar Misra has been conferred the prestigious American Association of Neurological Surgeons' 'International Lifetime Achievement Award in Neurosurgery'.
EXAMIANS